Ginkgo Bioworks Holdings (DNA) Short-term Investments (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has reported Short-term Investments for 5 consecutive years, with $255.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $255.4 million; the trailing twelve-month figure through Dec 2025 stood at $255.4 million (changed N/A YoY), and the FY2025 full-year result was $255.4 million, changed N/A from the prior year.
• Short-term Investments climbed to $255.4 million in Q4 2025 per DNA's latest filing, from $19.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $255.4 million in Q4 2025 and bottomed at $15.2 million in Q1 2022.
• Historically, Short-term Investments has averaged $47.6 million across 4 years, with a median of $22.5 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Short-term Investments jumped 87.47% in 2021, then declined 15.48% in 2023.
• Over 4 years, Short-term Investments stood at $25.7 million in 2021, then increased by 0.15% to $25.7 million in 2022, then slipped by 22.7% to $19.9 million in 2023, then jumped by 1185.06% to $255.4 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $255.4 million, $19.9 million, and $21.5 million for Q4 2025, Q2 2023, and Q1 2023 respectively.